Bookmark to:
       

Popular Health Products

Are You Worried about Health Symptoms? Ask the Health Expert!
Our Experts are Experienced Certified Health Care Professionals! and Most questions are answered in minutes! Type your question here

 letters left

MEASLES + MUMPS + RUBELLA (MMR II) Safety Reports

Total MEASLES + MUMPS + RUBELLA (MMR II) reports: 448.

< Previous  Showing 151-200 of 448 Next >

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from KY on May 24, 2007. Male patient , child 1.3 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a licensed practical nurse concerning a 5 year old male on 21 Aug 2001 was vaccinated with a dose of Varivax (lot # 637667/1606K). Concomitant vaccination included a dose of MMR II. On 04 Apr 2006 it was reported that ""within the last 102 weeks"" the patient experienced breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. Followup information from the nurse indicated that all the information on the varicella vaccine and the chicken pox was submitted. No further information is available.". . unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Female patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse (RN) concerning a 43-month-old black female who on 01-MAY-2003 was vaccinated subcutaneously in the right thigh with a first dose of Varivax (lot# 641712/0423M). Concomitant therapy included a dose of MMR II. On 15-OCT-2005 the patient had an adverse experience. Unspecified medical attention was sought and it was noted that there was ""confirmation (at an) office visit."" Subsequently, the patient recovered from the adverse experience on an unspecified date. Additional information has been requested.". . Unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from on May 24, 2007. Female patient , child 3 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a consumer concerning her daughter with no known medical history or allergies who in October 2005 was vaccinated IM in the gluteal muscle with a dose of Varivax. Concomitant vaccination included a dose of MMR II. Subsequently, the patient experienced spots on her stomach and behind the ears. Unspecified medical attention was sought. Subsequently the patient recovered. There was no product quality complaint involved. Additional information has been requested.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from IL on May 24, 2007. Female patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a health professional concerning a 45 month old female who on 05-AUG-2003, at 6:30 pm, was vaccinated with a first 0.5 ml subcutaneous dose in the left thigh of Varicella (Lot# 643824/0870M). Concomitant vaccine administered at the same time included a first subcutaneous dose in right thigh of MMR II (Lot# 643953/0926M). On 21-APR-2006 the patient developed a vesicular rash of about 50-60 lesions. It was noted that the rash was found over the child's entire body. The patient was treated with over the counter Benadryl and calamine lotion. At the time of the report the patient was recovering. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided."" Follow-up information from a health professional indicated that the patient was seen by a physician on 22-APR-2006 with one day of rash and fever beginning on 21-APR-2006, with 50-60 papular and vesicular lesions on her trunk, face, scalp, extremities, and pharyngeal mucosa. It was noted that the patient was exposed to Varicella 2-3 weeks prior. The patient was treated with calamine lotion, Benadryl, oral administration. No aspirin (A.S.A.) or ibuprofen was used. It was noted that the patient recovered. Additional information has been requested.". . Unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Female patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning an 11 year old female who on 01-MAY-1996 was vaccinated with a first dose of Varivax. Concomitant vaccination included a first dose of MMR II. On 12-APR-2006 the patient developed a ""bad case"" of breakthrough chickenpox disease. Unspecified medical attention was sought. Subsequently, the patient recovered. No further information was available. The patient's additional vaccination history includes: first, second, third and fourth doses of diphtheria toxoid (+) Hib conj vaccine (CRM197) (+) pertussis whole cell vaccine (+) tetanus toxoid (manufacturer unspecified) on 05-JUN-1995, 21-AUG-1995, 20-OCT-1995, and 30-JUL-1996 respectively. First, second, third and fourth doses of hepatitis B virus vaccine rHBsAg (yeast) (manufacturer unspecified) on 08-APR-1995, 05-JUN-1995, 30-JUL-1996, and 29-AUG-2001 respectively. One dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (manufacturer unspecified) on 05-JUN-1995. Doses of influenza virus split virion 3v vaccine inactivated on 04-DEC-2000 (FLUSHIELD) (lot # 4008210). On 09-NOV-2004 (FLUZONE) (lot # U1515AA), and 29-NOV-2005 (FLUZONE) (lot # U1916AA). One dose of poliovirus vaccine inactivated (unspecified) (IPOL) (lot # R1366) on 21-AUG-2000. A second dose of MMR II (lot # ""0577"") on 21-AUG-2000. First, second and third doses of poliovirus vaccine live oral (manufacturer unspecified) on 05-JUN-1995, 21-AUG-1995, and 30-JUL-1996 respectively. First and second doses of Infanrix on 21-AUG-2000 (lot # U0137BA) and 15-JUL-2005. Additional information is not expected.". . Unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Male patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning a 20 month old male who on 20-JUL-2005 was vaccinated SC in the left thigh with a first 0.5 ml dose of Varivax (lot # 650224/1107F). Concomitant vaccination included a 0.5 ml first dose of MMR II (lot # 646857/0850F) and a 0.5 ml fourth dose of Prevnar (lot # A67185K). On 27-MAR-2006 the patient developed breakthrough chickenpox disease. Unspecified medical attention was sought. Subsequently, the patient recovered. No further information was available. The patient's additional vaccination history includes: First, second, third, and fourth doses of Infanrix on 14-SEP-2004 (lot # AC21A003BA), 24-NOV-2004 (lot # AC21A005AA), 12-JAN-2005 (lot # AC21A010CA), and 01-DEC-2005 (lot # AC14A007AA) respectively. Doses of Fluzone on 12-JAN-2005 (lot # U1557AA) and 01-DEC-2005 (lot # U1916AA). First, second, third, and fourth doses of Prevnar on 14-SEP-2004 (lot # 495-932), 24-NOV-2004 (lot # A57561A), 12-JAN-2005 (lot # A74399D), and 20-JUL-2005 (lot # A67185K) respectively. One dose of hepatitis B virus vaccine (manufacturer unspecified) on 08-JUL-2004. Additional information is not expected.". . Unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from on May 24, 2007. Female patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning a 4-year-old female who on 08-FEB-2002 was vaccinated SC in the left arm with a first 0.5mL dos eof Varivax (Lot # 635794/0582L). Concomitant therapy that day included a first 0.5mL dose of MMR II (Lot # 639621/0899L). Other therapy included: a second 0.5mL dose of MMR II (Lot # 646585/0852P) administered on 03-FEB-2005; a first, second, third, fourth, and fifth 0.5mL dose of Infanrix on 02-APR-2001 (Lot # 983a2), 05-JUN-2001 (Lot # DTPa997a2), 02-AUG-2001 (Lot # DTPa505a2), 10-JUL-2002 (Lot # DTaP552A2), and 03-FEB-2005 (Lot # DTPa639A2); first 0.5mL dose of hepatitis A virus vaccine inactivated (Lot # 648218/0858P) on 28-FEB-2005; a first, second, and third 0.5mL dose of hepatitis B virus (+) Hib conj vaccine on 02-APR-2001 (Lot # 636992/1968K), 05-JUN-2001 (Lot # 638842/1763K), and 10-JUL-2002 (Lot # 643051/0284M); a 0.25mL dose of Fluzone on 05-DEC-2003 (Lot # U1269AA), 08-JAN-2004 (Lot # U1133AA), and 16-NOV-2004 (Lot # U1515AA); a first, second, third, and fourth 0.5mL dose of IPOL on 02-APR-2001 (Lot # R0516), 05-JUN-2001 (Lot # T0563), 10-JUL-2002 (Lot # UO422), and 03-FEB-2005 (Lot # W07501); and a first and second 0.5mL dose of Prevnar on 02-APR-2001 (Lot # 472046) and 02-AUG-2001 (Lot # 479-298). On 14-JAN-2006 the patient experienced breakthrough chickenpox disease. Subsequently, the patient recovered. No additional information is expected.". . Unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Female patient , child 1.3 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning a 10 year old white female, with unknown drug reaction/allergies, no adverse events following prior vaccinations and no illness at the time of vaccination. Vaccination history included the patient received 3 doses of DPT and Hep B on 24 May 1996, 19 Jul 1996 and 13 Sep 1996, 3 doses of Hep B on 24 May 1996, 19 Jul 1996 and 13 Sep 1996. 3 doses of Polio on 24 May 1996, 19 Jul 1996 and 13 Sep 1996, Hep B vaccine (generic) on 22 FEb 1996, 24 May 1996 and 13 Sep 1996. ON 06 Jun 1997 the patient was vaccinated subcutaneoulsy with a 0.5 mL dose of Varivax (Lot # 619271/1338D). On 06 Jun 1997 the patient was also vaccinated with DTP, HIB, MMR (lot # 618890/1247D). On 18 Apr 2006 the patient developed chicken pox. The rash consisted of 100 to 150 lesions (previously reported as greater than 50 lesions) over her eintire body. Most of the lesions were located on the client's arms, face and legs. The rash was itchy and lasted for about a week. The child also had low grade fever. Treatments included Tylenol, oatmeal, baths, vitamin C and anti itch lotion. The patient did not undergo any diagnostic/lab tests. On 23 Apr 2006 the lesions were scabbed and the patient fully recovered. No product quality complaint was involved. On 03 May 2001 the patient was vaccinated with DPT, MMR II (lot 634427/F1390K). Additional information is not expected.". "HIB, DTP vaccine adsorbed USP". unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Male patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse (RN) concerning a phone call from the mother of a 6-year-old white male with no known drug allergy who on 09-MAY-2001 was vaccinated subcutaneously in the left thigh with a first dose of Varivax (lot# 637957/1882K). Concomitant therapy included a first dose of MMR II (lot# 638373/0164L) given subcutaneously in the right thigh. There was no illness at the time of vaccination. On 12-MAY-2006 the patient developed a rash described as small, pinpoint and red with blisters in some areas. The rash was in small clusters on his chest, back and neck and was itchy. No fever was reported. No medical attention was sought; no laboratory or diagnostic tests were performed. Additional information has been requested.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Male patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a health professional concerning a 7 year old white male with no known allergies who on 03-JUN-1999 was vaccinated SC in the right thigh with a first dose of Varivax (lot # 630037/0290J). Concomitant therapy included a first dose in the right thigh SC of MMR (lot # 630101/0117J). There was no illness at the time of vaccination. On 10-MAY-2006 the patient's mother reported that he had little red dots on his shoulders and a few on his back. He complained of itchiness. Some spots were crusted over. It was a ""very light case"" per mom. No labs were done and no medical attention was sought. Subsequently the patient recovered. Additional information has been requested.". . Unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Female patient , child 1.3 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a woman in a physician's office concerning a 7 year old female with no allergies or medical conditions who on 04-APR-2000 was vaccinated SC in the left vastus lateralis with a first dose of Varivax (lot # 632042/1360J). Concomitant vaccination on the same day included a SC first dose in the right vastus lateralis of MMR II (lot # 634036/1711J). There was no illness at the time of vaccination. On 16-MAY-2006, the patient broke out with chickenpox lesions and was seen by the physician. No diagnostic laboratory tests were performed. The patient recovered on an unspecified date in May 2006. It was noted that the patient had no adverse events following prior vaccination. Additional information is not expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Male patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning a 4-year-old male with no pertinent medical history and no drug reactions/allergies on 29-AUG-2002 was vaccinated with a 0.5mL dose of Varivax (Lot # 641157/0079M). It was unknown if there was an illness at the time of vaccination. Concomitant therapy included a dose of MMR II (Lot # 643499/0538M). There was no other concomitant medication. On 10-JUN-2006 the patient experienced about 30 vesicular lesions, mostly on his trunk. No other symptoms were noted. No other information was available. The outcome was reported as recovering. Unspecified medical attention was sought. There was no product quality complaint involved. There were no relevant diagnostic tests or laboratory data. Follow-up information indicated that on 12-JUN-2006, the patient developed a rash without fever or other symptoms. Approximately 30-35 papules were noted. The outcome was recovered. No additional information is expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from TX on May 24, 2007. Female patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. Information has been received from a licensed practical nurse concerning a 9 year old white female with no known medical history or allergies who on 11-DEC-1997 was vaccinated with a first dose of Varivax. Concomitant vaccination administered that day included a dose of MMR. There was no illness at the time of vaccination. On 07-JUN-2006 the patient developed a chicken pox rash with vesicles. There were less than 50 lesions located on her chin and back. No laboratory diagnostic tests performed. There were no adverse events following prior vaccination. At the time of the report the patient was still recovering. Additional information has been requested.. . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from CA on May 24, 2007. Male patient , child 1.4 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a health professional concerning a 17 month old male with no known medical history or allergies who on 05-JUN-2006 was vaccinated SC with a 0.5 mL Varivax (lot # 652664/1033R). Suspect vaccination administered on the same day included a 0.5 mL SC dose of MMR (lot # 653317/0211F). ""Around"" 09-JUN-2006 the patient developed a rash on the face and body. It was reported that the rash had gotten worse. At the time of the report the patient had not recovered. Unspecified medical attention was sought. No laboratory diagnostic tests were performed. It was also mentioned that a rash occurred with other patients. There was no product quality complaint involved. Additional information has been requested.". Unknown. None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from on May 24, 2007. Female patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. Information has been received concerning an 8 year old white female with an allergy to SEPTRA who on 29-JUL-1998 was vaccinated with a SC dose of Varivax (lot # 626956/0837H). Suspect vaccination administered that day included a SC dose of MMR (lot # 627842/0798H). There was no illness at the time of vaccination. On 06-JUN-2006 the patient developed a rash. Medical attention was sought and no laboratory tests were performed. The patient's outcome was recovered on 06-JUN-2006. It was reported that the patient's brother (WAES# 0606USA04668) had as similar experience after vaccination with Varivax. Additional information is not expected.. Unknown. . Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from PA on May 24, 2007. Female patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse (R.N.) concerning a 14-month-old female (23 lb, 29.5 in) with no pertinent medical history or allergies, who on 27-APR-2006 was vaccinated subcutaneously in the left arm with a 0.5 ml first dose of Varivax (lot# 649998/0909R). Concomitant vaccination given on the same day included a first dose of MMR II (lot# 650105/0829R) given subcutaneously in the right arm and sodium fluoride. There was no illness at the time of vaccination. On 07-JUL-2006 the patient developed varicella. Unspecified medical attention was sought. It was reported that the patient had 50 lesions or more on various areas on her body, such as her scalp, underarms, arms, legs trunk and back. No laboratory or diagnostic tests were performed. TYLENOL and comfort measures were recommended to help with the symptoms. The patient recovered as of 20-JUL-2006. No product quality complaint was involved. The reporter considered the adverse experience to be other important medical event. Additional information has been requested.". sodium fluoride. None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Female patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a physician concerning an 8 year old female with no known allergies who on 13-May-1999 was vaccinated SC in the right arm with a first dose of Varivax (Oka/Merck) (lot# 629613/0285J). Concomitant vaccination included a first dose of MMR II (lot# 629567/1793H) given SC in the left arm. On 07-JUL-2006 the patient experienced rash, fever of 103 and headache. The fever lasted for one day. On 11-JUN-2006 the patient recovered. There was no product quality complaint involved. Additional information is not expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from FL on May 24, 2007. Male patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. Information has been received from a physician concerning a 9 year old male with no known medical history or allergies who on 09-DEC-1997 was vaccinated SC in the left thigh with a first dose of Varivax (lot # 623135/0689E). Concomitant vaccination included a SC first dose in the right thigh of MMR II (lot # 622737/0739E). There was no illness at the time of vaccination. On 15-JUL-2006 (also reported as 17-JUL-2006) the patient developed many pox (rash) on back and chest. Medical attention was not sought. The patient recovered on 24-JUL-2006. Additional information has been requested.. . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from KY on May 24, 2007. Female patient , child 1.2 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a physician's office concerning a 6 year old female with no known allergies or past medical history who on 15-JUN-2001 was vaccinated SC in the right arm with a dose of Varivax (lot# 636368/1341K). Concomitant vaccination included a dose of MMR (lot #638359/0163L) SC in the left arm. There was no illness at the time of vaccination. On 12-JUL-2006 the patient developed 10-15 scattered vesicular lesions all over. The patient was treated with diphenhydramine hydrochloride (Benadryl). Subsequently, the patient recovered. Additional information is not expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from NY on May 24, 2007. Female patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a physician concerning a 5 year old female with no known allergies or past medical history who on 21-DEC-2001 was vaccinated in the left thigh with a first 0.5 ml dose of Varivax (lot#638931/1144L). Concomitant vaccination included a first dose of MMR. There was no illness at the time of vaccination. On 30-JUL-2006 the patient developed right chest and back pain. On 31-JUL-2006 the patient developed a painful polyvesicular rash with dermatomal distribution on her anterior and posterior trunk, which was noted to be herpes zoster. The patient rated her pain at 8 on a scale of 0 (LEAST)-10(most). Maximum temperature was 98.3 F. It was reported that the patient has not had a recent exposure to chickenpox or shingles. The patient was enrolled in the VZVIP program: the Varicella Zoster Virus Identification Program enables biological samples to be analyzed by PCR to identify if VZV is present and if it is present to identify if it is associated with the wild-type VZV strain or with the vaccine VZV strain. On 01-AUG-2006 the patient was seen by the physician, specimens were obtained from vesicles on her anterior and posterior torso, and sent for PCR analysis and it was found to be vaccine strain, previously reported as wild type strain. It was reported that VZV DNA was amplified but that B-globin DNA was not amplified. Subsequently, the patient recovered. It was reported that there was no adverse events following prior vaccination with the patient or her siblings. There was no product quality complaint involved. Additional information is not expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from IL on May 24, 2007. Male patient , child 1.2 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse (R.N.) concerning a 15-month-old male with no pertinent medical history or allergies, who on 05-JUL-2006 was vaccinated subcutaneously one time with a 0.5 ml dose of Varivax (lot# 654330/0492F). Concomitant therapy included TYLENOL given prior to the vaccination for the prevention of pain and fever and a vaccination with a dose of MMR. On 30-JUL-2006 the patient started breaking out with what looked like large pimples that were red and raised that blistered then broke and scabbed over within 24 hours. The patient's mother treated him with DIMETAPP (new formula). More breakouts occurred over more areas. The areas with the breakouts were itchy. The nurse mentioned that the child ran a fever before the breakouts occurred. As of 02-AUG-2006 the patient was still having breakouts. As of 09-AUG-2006 the patient was recovered. This was considered to be a non-serious report. No product quality complaint was involved. The nurse indicated in follow-up that the event did not require intervention to prevent serious criteria. Additional information has been requested.". TYLENOL. . Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from NJ on May 24, 2007. Male patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning a 6 year old male child with no known allergies or past medical history who on 29-JUN-2001 was vaccinated SC with a first dose of Varivax (lot# 638652/0233L). Concomitant vaccination included a first dose of MMR (lot # 638702/0253L) given SC. On 08-AUG-2006 (also reported as 07-AUG-2006), the patient presented with 35-40 itchy, ""insect bite like lesions"" on his chest, back and legs. No other symptoms were noted. The patient was treated with BENADRYL. Subsequently, the patient recovered. There was no product quality complaint involved. Additional information is not expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from NJ on May 24, 2007. Male patient , child 1.3 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse (R.N.) concerning a 36-month-old white male (31 lb., 38 in.) with no pre-existing allergies, birth defects or medical conditions, who on 27-OCT-2004 was vaccinates subcutaneously in the arm with a first dose of Varivax (lot# 648757/0594P). Concomitant vaccination included a first dose of MMR (lot# 648144/0042P) given subcutaneously in the arm on 27-OCT-2004 and a first dose of FLUZONE (lot# U1442AA) given intramuscularly in the arm on 23-OCT-2004. There was no illness at the time of vaccination. There was no rash at the injection site or elsewhere within 42 days of the vaccination. On 05-AUG-2006 the patient developed a cluster of blisters on his left shoulder with a sharp border medially. He was seen by a physician and diagnosed with shingles. It was reported that there was no history of chickenpox or exposure to chickenpox or herpes zoster. No laboratory or diagnostic tests were performed. It was reported that the patient had no pain and was treated with acyclovir for five days. At the time of this report the patient recovered. Additional information has been requested.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from IN on May 24, 2007. Male patient , child 01 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. Information has been received from a certified medical assistant concerning a 4 year old male with no known medical history or allergies who on 24-JAN-2003 was vaccinated SC in the left arm with 0.5 mL first dose of Varivax (lot # 643594/0808M). Concomitant vaccination administered that day included a SC first dose in the right arm of MMR. There was no illness at the time of vaccination. On 02-AUG-2006 the patient broke out in a rash. It was reported that the patient developed chickenpox with 50 papules scattered on the body. BENADRYL and AVEENO BATH were used as treatment. Medical attention was not sought. No laboratory diagnostic tests were performed. There were no adverse events following prior vaccination. Additional information has been requested.. . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from PA on May 24, 2007. Male patient , child 1.3 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse and physician concerning a 7-year-old male with no known allergies or past medical history who on 29-JUN-2000 was vaccinated in the right thigh with a 0.5 first dose of Varivax (lot# 632718/1856J). Concomitant vaccination included a first dose of MMR II (lot # 632456/0173K) given in the left thigh. No rash occurred at the injection site or elsewhere within 42 days of vaccination. On 19-AUG-2006 the patient experienced left arm pain. On 20-AUG-2006, the patient developed a ""herpes zoster rash"" on his left arm. On 22-AUG-2006, the patient was seen at the physician's office having a ""shingles-like rash"" from his left shoulder to the radial side of his wrist. He was diagnosed with shingles. The patient also had a temperature of 101.7, a headache and a sore throat. The patient rated his pain 1 on a scale of 0 (least) to 10 (most). It was reported that the patient does not have a history of chickenpox, and that it was unknown if the patient has a recent exposure to chickenpox or herpes zoster. There was no specimen collected for PCR and a direct fluorescent antibody was not done, no other diagnostic test or labs were performed. The boy was treated with BENADRYL and acyclovir. On 01-SEP-2006 the patient recovered. The reporter considered the shingles to be an other important medical event. Additional information is not expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from NJ on May 24, 2007. Male patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning a 10-year-old male with a milk allergy and a history of reactive airways disease who on 26-OCT-1996 was vaccinated SC in the left arm with a first 0.5mL dose of Varivax (Lot # 617695/0776D). There was no illness at the time of vaccination. Concomitant therapy that day included a first dose of MMR (Lot # 618613/0469D) administered SC> There were no other concomitant medication. On 05-SEP-2006 the patient presented to the physician's office with an itchy rash all over his body (face, back, and groin area). He was treated with BENADRYL and CALAMINE LOTION. The patient's itchy rash persisted. There were no lab diagnostic studies performed. There was no product quality complaint. Follow up information received from a registered nurse indicated that on 05-SEP-2006 the patient developed 100-200 lesions on his face, back, chest, and groin. He was given symptomatic treatment. The outcome was recovered. No additional information is expected.". . Reactive airways disease. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from NJ on May 24, 2007. Female patient , child 1.2 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning an 11 year old female with no reported history or allergies who on 09 Jul 1996 was vaccinated with a SC first dose of Varivax (Lot # 617224/0252D). Suspect vaccination administered the same day included an SC first dose of MMR II (lot # 616454/0382D). There was no illness at the time of vaccination. On 02 Sep 2006 (previously reported as On 26 Sep 2006) the patient developed a varicella-like rash on her back, chest, and wrist. The number of lesions ranged from 25-30. They were also described as 25-30 insect bite like lesions on legs, back, chest, and wrist. No other symptoms were noted. Symptomatic treatment was given including OTC calamine lotion and Benadryl. Subsequently the patient recovered. Additional information is not expected.". . none. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from CO on May 24, 2007. Female patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a physician concerning a 33 month old white female with no known allergies or medical history, who on 14-JAN-2005 was vaccinated in the right thigh with a dose of Varivax (lot # 648317/0439P). Concomitant vaccination included a first dose of MMR (lot # 647282/0345P) given in the left thigh. There were no other concomitant medications. There was no illness at the time of vaccination. On 07-OCT-2006 the patient presented to the physician's office with shingles that appeared below her left breast on the chest, also reported as herpes zoster on the left chest wall, T7 and T8 dermatomes. It was reported that it did not seem to be painful. At the time of the report the patient had not recovered. It was reported that the patient has not had adverse events following prior vaccinations. No further information was available. There was no product quality complaint involved. Additional information has been requested.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Male patient , child 1.2 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a certified medical assistant concerning a 25 month old white male who on 07-DEC-2005 was vaccinated SC in the left thigh with a first dose of Varivax (lot # 649739/0121R). Concomitant vaccination on the same day included a SC first dose in the right thigh of MMR (lot # ""653153/0996R""-invalid for this product). There was no illness at the time of vaccination. On 10-OCT-2006, the patient developed chickenpox which was confirmed in the physician's office on 11-OCT-2006. It was described as pink, itchy pox mostly on the patient's stomach. The patient's outcome was unknown. Additional information is not expected.". . Unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Female patient , child 1.3 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a health professional concerning a 44-month-old female who on 08-JUN-2004 was vaccinated SC in the right leg with a first dose of Varivax (Lot # 641710/04252N). Concomitant therapy that day included a first dose of MMR II (Lot # 644707/0040P) administered SC in the left leg. On 26-OCT-2006 the patient experienced breakthrough chickenpox. Subsequently, the patient recovered from chickenpox on 06-NOV-2006. Unspecified medical attention was sought. Additional information has been requested.". . Unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Female patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a licensed practical nurse concerning a 17-month-old white female with no known pre-existing allergies, birth defects, or medical conditions who on 19-JUN-2006 was vaccinated SC with the first dose of varicella virus vaccine live (Oka/Merck) (lot # 652629/1031R). There was no illness at the time of the vaccination. Concomitant therapy that day included a first dose of measles-mumps-rubella vaccine (MSD) (Lot # 653338/0216F) administered SC and a forth dose of pneumococcal 4 6B 9V 18C 19F 23F conj vaccine (CRM197) (PREVNAR) (Batch # B06641A) administered IM. On 16-NOV-2006 the patient developed a rash with less than 50 lesions. Subsequently, the patient recovered. It was noted that the patient's father had shingles. There were no relevant diagnostic tests or laboratory data. Additional information has been requested.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from KY on May 24, 2007. Male patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a certified medical assistant (C.M.A.) concerning a 6-year-old male with a history of mild lymphoid hyperplasia and no allergies, who on 25-APR-2001 was vaccinated subcutaneously in the left arm with one dose of Varivax (lot # reported as ""1574K"") and ""1314K""). Concomitant vaccination included a dose of MMR II (lot# 631048/0105K) given subcutaneously in his right arm and the patient also had Tubersol (lot# C0999AA) given intradermally in the right forearm. There was no illness at the time of vaccination. On 27-NOV-2006, after the child was exposed at school, the patient developed chickenpox, characterized by 15-20 eruptions on his face, trunk, arms and legs. Unspecified medical treatment was sought and the patient was treated with diphenhydramine hydrochloride (Benadryl). No laboratory or diagnostic tests were performed. At the time of this report the patient had recovered. No product quality complaint was involved. Additional information is not expected.". Tubersol. Lymphoid tissue hyperplasia. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from NJ on May 24, 2007. Male patient , child 1.4 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning a 12 year old male with no medical history or allergies who on 03-OCT-1995 was vaccinated with a first dose in the right arm of Varivax (lot # 608655/0417B). Concomitant therapy vaccination that day included a first dose in the left arm of MMR II (lot # 615839/0885B). There was no illness at the time of vaccination. On 27-NOV-2006 the patient developed a fever of 104 and lesions on face, trunk, and buttocks with a total of 75. Medical attention was sought. No laboratory diagnostic tests were performed. Treatment was symptomatic. Subsequently, the patient recovered. The patient did not experience any adverse events following prior vaccination. There was no product quality complaint involved. Additional information is not expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from on May 24, 2007. Male patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a nurse concerning a 15 month old male who in September 2006, was vaccinated subcutaneously with Varivax, as well as MMR II, and other unidentified vaccinations. On around 23-NOV-2006 the patient developed shingles, which was believed to be a result of the Varivax vaccine, the patient received in SEP 2006. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.". Unknown. Unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from MD on May 24, 2007. Male patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a healthcare worker concerning a 7-year-old male with no pertinent medical history or allergies who on 02-OCT-2000 (also reported as 20-OCT-2000) was vaccinated in the arm with a 0.5 mL dose of Varivax (Lot #635452/0768K). Concomitant therapy included MMR II. There was no illness at the time of vaccination. On 09-JAN-2007 at 09:00, the patient experienced a generalized, scattered papular rash which was itchy for 4-5 days. Unspecified medical attention was sought. The patient was diagnosed with chicken pox. No diagnostic studies or lab tests were performed. On 16-JAN-2007 the patient recovered. No additional information was provided. There was no product quality complaint involved. Additional information is not expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from TX on May 24, 2007. Female patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a physician concerning her 8-year-old daughter who on 17-MAR-1999 was vaccinated subcutaneously in the left arm with a 0.5 ml dose of Varivax (Lot # 629249/1845H). Concomitant medication on that day was MMR (Lot # ""121408/03""). On 02-JAN-2007 (previously reported as 03-JAN-2007), the patient experienced a breakthrough of approximately 50 lesions of varicella rash. It was noted that this was a ""mild case"" of varicella disease. The outcome was reported as recovered. Unspecified medical attention was sought. No additional information to report. There was no product quality complaint involved. No additional information is expected.". . Unknown. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from KY on May 24, 2007. Female patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 18, 2007. "Information has been received from a certified medical assistant concerning a 4 year old female with seasonal allergies, congestion, pyloric stenosis (diagnosed in January 2003), a cefdinir (OMNICEF) hypersensitivity and a history of tubes (in 2004), who on 18-NOV-2003 was vaccinated SC with a 0.5 ml dose of Varivax (lot # 646140/0539N). Concomitant vaccination included a first dose of ProQuad (lot # 640788/1180M) given SC. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). There was no illness at the time of vaccination. On 10-JAN-2007 the patient experienced an unspecified amount of lesions and red papules on the trunk. The patient was afebrile. Medical attention was sought, the patient was seen in the office on 11-JAN-2007 and was diagnosed with chickenpox. There were no lab studies performed. The patient was treated with oral diphenhydramine hydrochloride (BENADRYL) capsules and calamine (+) zinc oxide (CALAMINE LOTION) topically as needed. On an unspecified date the patient recovered. There was no product quality complaint involved. No further information was provided. The patient's vaccination history also included a second dose of MMR (lot # 655063/0861F) given SC on 18-NOV-2006. Additional information is not expected.". Zyrtec. Ear tube insertion. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Male patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning a 9 year old male with no allergies or medical history who on 26-JUN-1998 was vaccinated SC in the right arm with a first dose of Varivax (lot # 625047/1574E). Concomitant vaccination on the same day included a SC first dose of MMR (lot # 623743/0505H). There was no illness at the time of vaccination. On 18-JAN-2007, the patient's mother stated that the child had one red spot on his face. By 19-JAN-2007, he had about 60 all over his body. They were itchy and slight painful. The patient recovered on an unspecified date. No diagnostic laboratory tests were performed. Additional information is not expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Male patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a health professional concerning a 9 year old white male (65 pounds, 50 inches) with no pre-existing allergies, birth defects, or medical conditions who on 07-JAN-1999 was vaccinated SC in the left arm with a first dose of Varivax (Lot# 628246/1655H). There was no illness at the time of vaccination. That same day the patient was also vaccinated with MMR (lot # 628895/1541H) subcutaneous in the right arm. On 15-JAN-2007 at 9:30AM the patient started with a few red bumps and then progressed to a total of 15. The location was right clavicle area/shoulder and upper arm in various stages of red pustulae with center scabs. No relevant drug tests or lab data were required. The patient recovered on 24-JAN-2007 (also reported as the rash lasted for 3 days). Additional information is not expected.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from LA on May 24, 2007. Female patient , child 1.0 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a certified medical assistant concerning a 6 year old female with no allergies or medical history who on 04-SEP-2001 was vaccinated SC with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck). Concomitant vaccination included a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus live (Wister RA 27/3) (Oka/Merck) (MSD). Over five years later, on 20-FEB-2007 the patient developed shingles on the left arm. She initially presented with one lesion and the lesions have progressed to multiple macular clustered vesicles from her shoulder to the hand. Unspecified medical attention was sought. The patient was being treated with acyclovir (Zovirax). No diagnostic laboratory tests were performed. The patient's shingles persisted. A product quality complaint was not involved. Additional information has been requested.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from OH on May 24, 2007. Male patient , child 1.2 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse (RN) concerning a 9 year old male with a concurrent condition of attention Deficit Hyperactivity Disorder (ADHD), with no reported drug reaction or allergies, who on 24-November-1998 was vaccinated with a first 0.5 ml dose intramuscularly with Varivax (Lot Number 626959/0846H). Concomitant therapy that day included a first MMR II, which was also administered on 24-November-1998, and dexmethylphenidate hydrochloride (FOCALIN) and atomoxetine hydrochloride (STRATTERA). On 21-February-2007, the patient developed chickenpox, including red lesions on the chest and back, along with a temperature of 101 F. The patient's was not recovered at the time of this report. Unspecified medical attention was sought. Follow up information indicated that on 21-FEB-2007 the patient developed red lesions on his chest and back for one week. There were scabbing over and his skin was sensitive and itching. He was treated with acyclovir 400mg TID. The outcome was recovered. The reporter considered the event to be an other important medical event. There was no product quality complaint. No additional information is expected.". "STRATTERA, FOCALIN". . Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from on May 24, 2007. Male patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 16, 2007. "Information has been received from a registered nurse concerning a 13-month-old male with no previous allergies or pertinent medical history who on 23-FEB-2007 was vaccinated subcutaneously with a 0.5 ml dose of Varivax (Lot # 654520/1152F). Concomitant therapy included MMR II. On 13-MAR-2007, the patient experienced chickenpox rash ""all over the body"" including near the eyes. Unspecified medical attention was sought. No laboratory or diagnostic studies were performed. The outcome was not provided. No additional information to report. There was no product quality complaint involved. Additional information has been requested.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from NY on May 25, 2007. Male patient , child 8 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 17, 2007. "13 x 11.5cm erythematous, warm, tender area right upper arm after vaccinated with MMR and VZV.". None. Obese. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from MO on May 29, 2007. Male patient , child 1.1 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 26, 2007. Pt. seen in our office on 5-22-07 and diagnosed with shingles to (R) lower extremity. Pt has numerous raised lesions to (R) LE. Eczema Cream. NKA. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from TX on May 29, 2007. Female patient , 49 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 23, 2007. 1-2 weeks after vaccination patient began having multiple joint pain and exacerbation of asthma. Continues to have these problems and does not feel well at all.. . ASTHMA. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from RI on May 29, 2007. Female patient , 49 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 24, 2007. "MMR 12/21/06 one week later, pain, swelling. Describes - neuralgia with pain radiating distally has residual muscle defect at injection site. No medical intervention.". . None. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from NE on May 30, 2007. Female patient , 23 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 22, 2007. Severe dizziness within 15 minutes of immunization. S/S increased a few hours after injection. She did not pass out.. . Diabetes Type I. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from TX on May 30, 2007. Male patient , 36 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 11, 2007. "Client reported that on 5/3/07 pm, after pre dawn, vaccines he experienced a pain in L arm radiating to neck. No swelling, No s/s of anaphylactic reac. Went to ER on 5/5/07 and 5/7/07 for pain. Was referred by ER to Clinic for F/U to evaluate for possible brachial neuritis VS herniated disc. Had appt on 5/15/2007 at clinic.". . Hypertension. Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from FL on May 30, 2007. Female patient , 48 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 30, 2007. Felt achy with joint pain. Fine rash on back and abdomen.. . . Patient recovered.

MEASLES + MUMPS + RUBELLA (MMR II) problem was reported from IL on May 31, 2007. Female patient , 61 years of age, was vaccinated with MEASLES + MUMPS + RUBELLA (MMR II) on May 31, 2007. "Developed erythema, induration, and pruritis around vaccination area (Tdap) on left upper anterior arm, 72 hours after vaccination. No treatment, symptoms have begun to resolve now (one week later) though some redness, induration, and pruritis remain. No other effect on left upper extremity.". "Plavix, Flobic (Vit b complex), Hyzaar, Declofenac, Patanol (eye drop), Premarin cream". None. Patient recovered.

< Previous  Showing 151-200 of 448 Next >